Merck Sharp and Dohme (MSD), a subsidiary of Merck & Co., Inc, invited Holmusk to showcase GlycoLeap at their Asia Pacific Tech Innovation Summit, held at The Star Performing Arts Centre from November 1-2, 2016.
GlycoLeap is an all-in-one diabetes management program that allows users to track their diet, blood glucose and weight.
We developed the program to support and guide people with Type 2 Diabetes towards positive and sustainable behaviour changes.
MSD gathers participants each year to share their expertise, knowledge and offer creative solutions. Participants included health consulting businesses like Accenture, healthcare software providers like SAP, as well as emerging local start-ups like Joytingle.
“The work you’re doing right now is important in impacting the lives of people with diabetes.”
– Vivianne Tay (Joytingle), Former ICU Nurse at National Heart Centre